{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:44Z","timestamp":1787026964078,"version":"build-2736575974"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Chronic Myeloid Leukemia is a neoplastic disease characterized by the abnormal expansion of hematopoietic cells with compromised functions. Leukemic cells often display a multidrug resistance phenotype, enabling them to evade a number of structurally unrelated cytotoxic compounds. One of those mechanisms relies on the high expression of efflux transporters, such as the ABC proteins, whose activity depends on the hydrolysis of ATP to reduce intracellular drug accumulation. In the present work, we employed a well-known erythroleukemia cell line, K562, and a multidrug resistant derivative cell, FEPS, to evaluate how hexokinase II, a key regulator for the rate-limiting step glycolysis, contributes to the establishment of the multidrug resistance phenotype. We found that multidrug resistant cells primarily resort to glycolysis to generate ATP. Clotrimazole reduced the expression of mitochondrial hexokinase II, which destabilized bioenergetic parameters such as reactive oxygen species production, ATP, and glutathione levels on multidrug resistant cells. This impaired the activity of ABCC1, leading to increased drug accumulation and cell death. In summary, we propose that decoupling of hexokinase II from the mitochondria emerges as a promising strategy to generate collateral sensitivity and aid in the management of chronic myeloid leukemia in chemotherapy-refractory patients.<\/jats:p>","DOI":"10.3389\/fonc.2022.852985","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T06:23:25Z","timestamp":1654237405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Detachment of Hexokinase II From Mitochondria Promotes Collateral Sensitivity in Multidrug Resistant Chronic Myeloid Leukemia Cells"],"prefix":"10.3389","volume":"12","author":[{"given":"Tha\u00eds","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica M.","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit\u00f3ria R.","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo J.","family":"Salustiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian M.","family":"Rumjanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Q.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23282","article-title":"Chronic Myeloid Leukemia: 2012 Update on Diagnosis, Monitoring, and Management","volume":"87","author":"Jabbour","year":"2012","journal-title":"AJH"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1042\/BSR20130067","article-title":"Multidrug Resistance in Chronic Myeloid Leukaemia: How Much can We Learn From MDR-CML Cell Lines? Biosci","volume":"33","author":"Rumjanek","year":"2013","journal-title":"Rep."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-431379","article-title":"BCR-ABL1 Compound Mutations in Tyrosine Kinase Inhibitor-Resistant CML: Frequency and Clonal Relationships","volume":"121","author":"Khorashad","year":"2013","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/leu.2010.238","article-title":"Seeking the Causes and Solutions to Imatinib-Resistance in Chronic Myeloid Leukemia","volume":"25","author":"Bixby","year":"2011","journal-title":"Leukemia."},{"key":"B5","article-title":"\u201cMulti-Drug Resistance in Cancer\u201d","volume-title":"Methods of Molecular Biology","author":"Gillet","year":"2010"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of Cancer Drug Resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu Rev Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a Better Understanding of the Complexity of Cancer Drug Resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu Rev Pharm Toxicol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23010119","article-title":"Towards Comprehension of the ABCB1\/P-Glycoprotein Role in Chronic Myeloid Leukemia","volume":"23","author":"Maia","year":"2018","journal-title":"Molecules."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/pl00000912","article-title":"From MDR to MXR: New Understanding of Multidrug Resistance Systems, Their Properties and Clinical Significance","volume":"58","author":"Litman","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0300-483X(01)00454-1","article-title":"Toxicological Relevance of the Multidrug Resistance Protein 1, MRP1 (ABCC1) and Related Transporters","author":"Leslie","year":"2001","journal-title":"Toxicology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02969.x","article-title":"Cells From Chronic Myelogenous Leukaemia Patients at Presentation Exhibit Multidrug Resistance Not Mediated by Either MDR1 or MRP1","volume":"114","author":"Carter","year":"2001","journal-title":"Br J Haematol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.672287","article-title":"Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib","volume":"11","author":"Loscocco","year":"2021","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12197","article-title":"Clinical Impact of ABCC1 and ABCC2 Genotypes and Haplotypes in Mediating Imatinib Resistance Among Chronic Myeloid Leukaemia Patients","volume":"39","author":"Au","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-009-9231-y","article-title":"Comparison of the Cytotoxic Effect of Lapachol, Alphalapachone and Pentacyclic 1,4-Naphthoquinones on Human Leukemic Cells","volume":"28","author":"Salustiano","year":"2010","journal-title":"Invest New Drug"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-010-9453-z","article-title":"LQB-118, a Pterocarpanquinone Structurally Related to Lapachol [2-Hydroxy-3-(3-Methyl-2-Butenyl)-1,4-Naphthoquinone]: A Novel Class of Agent With High Apoptotic Effect in Chronic Myeloid Leukemia Cells","volume":"29","author":"Maia","year":"2011","journal-title":"Invest New Drugs"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming Glucose Metabolism in Cancer: Can It be Exploited for Cancer Therapy","volume":"16","author":"Hay","year":"2016","journal-title":"Nat Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tibs.2018.01.006","article-title":"Metabolic Kinases Moonlighting as Protein Kinases","author":"Lu","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.701975","article-title":"Moonlighting Proteins: The Case of the Hexokinases","volume":"8","author":"Rodr\u00edguez Saavedra","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2174\/187152008783961932","article-title":"The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen","volume":"8","author":"Lopez-Lazaro","year":"2008","journal-title":"Anti-Canc Agents Med Chem"},{"key":"B20","first-page":"15","article-title":"SIRT2 is a Tumor Suppressor That Connects Aging, Acetylome, Cell Cycle Signaling, and Carcinogenesis","volume":"1","author":"Park","year":"2012","journal-title":"Transl Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M403835200","article-title":"Mitochondrial Bound Hexokinase Activity as a Preventive Antioxidant Defense. Steady-State ADP Formation as a Regulatory Mechanism of Membrane Potential and Reactive Oxygen Species Generation in Mitochondria","volume":"279","author":"Da-Silva","year":"2004","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23425","article-title":"Up-Regulation of Hexokinase II Contributes to Rituximab Chemotherapy Resistance and Is a Clinically Relevant Target for Therapeutic Development","volume":"9","author":"Gu","year":"2018","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2010.03.002","article-title":"VDAC, a Multi-Functional Mitochondrial Protein Regulating Cell Life and Death","volume":"31","author":"Shoshan-Barmatz","year":"2010","journal-title":"Mol Aspect Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V45.3.321.bloodjournal453321","article-title":"Human Chronic Myelogenous Leukemia Cell-Line With Positive Philadelphia Chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2014.06.001","article-title":"Changes in Gene Expression Profile in Two Multidrug Resistant Cell Lines Derived From a Same Drug Sensitive Cell Line","volume":"38","author":"Moreira","year":"2014","journal-title":"Leuk Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1761-0","article-title":"Characterization of a Multidrug-Resistant Chronic Myeloid Leukemia Cell Line Presenting Multiple Resistance Mechanisms","volume":"383","author":"Daflon-Yunes","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013090","article-title":"Inhibition of Glycosphingolipid Biosynthesis Reverts Multidrug Resistance by Differentially Modulating ABC Transporters in Chronic Myeloid Leukemias","volume":"295","author":"Salustiano","year":"2020","journal-title":"J Biol Chem"},{"key":"B28","first-page":"473","article-title":"Culture of Animal Cells: A Manual of Basic Techniques and Specialized Applications","volume":"6","author":"Freshney","year":"2016","journal-title":"Wiley"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta DeltaC(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/mnfr.200700470","article-title":"Targeting of Cancer Energy Metabolism","volume":"53","author":"Rodr\u00edguez-Enr\u00edquez","year":"2009","journal-title":"Mol Nutr Food Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0444.1000219","article-title":"Clotrimazole as a Cancer Drug: A Short Review","volume":"4","author":"Kadavakollu","year":"2014","journal-title":"Med Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01507-0","article-title":"Clotrimazole and Bifonazole Detach Hexokinase From Mitochondria of Melanoma Cells","volume":"342","author":"Penso","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(90)86134-h","article-title":"Determination of Aldehydic Lipidperoxidation Products: Malonaldehyde and 4-Hydroxynonenal","volume":"186","author":"Esterbauer","year":"1990","journal-title":"Methods Enzymol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.378","article-title":"Assay for Quantitative Determination of Glutathione and Glutathione Disulfide Levels Using Enzymatic Recycling Method","volume":"1","author":"Rahman","year":"2007","journal-title":"Nat Protoc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.r114.609248","article-title":"Multidrug Resistance Protein 1 (MRP1, ABCC1), A \u201cMultitasking\u201d ATP-Binding Cassette (ABC)","volume":"289","author":"Cole","year":"2014","journal-title":"Transport J.B.C."},{"key":"B36","article-title":"Reversal Mechanism of Multidrug Resistance by Verapamil: Direct Binding of Verapamil to P-Glycoprotein on Specific Sites and Transport of Verapamil Outward Across the Plasma Membrane of K562\/ADM Cells","volume":"49","author":"Yusa","year":"1989","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.10.015","article-title":"Evaluation and Comparison of MRP1 Activity With Three Fluorescent Dyes and Three Modulators in Leukemic Cell Lines","volume":"28","author":"Dogan","year":"2004","journal-title":"Leuk Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0005-2728(02)00248-7","article-title":"Mitochondrial Bound Type II Hexokinase: A Key Player in the Growth and Survival of Many Cancers and an Ideal Prospect for Therapeutic Intervention","volume":"10","author":"Pedersen","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of Mammalian Hexokinase: Structure, Subcellular Localization and Metabolic Function","volume":"206","author":"Wilson","year":"2003","journal-title":"J Exp Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BFb0049776","article-title":"Hexokinases","volume":"126","author":"Wilson","year":"1995","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(00)00201-8","article-title":"Kinetic Characterization of Hexokinase Isoenzymes From Glioma Cells: Implications for FDG Imaging of Human Brain Tumors","volume":"28","author":"Muzi","year":"2001","journal-title":"Nucl Med Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/febs.12864","article-title":"Modeling Cancer Glycolysis Under Hypoglycemia, and the Role Played by the Differential Expression of Glycolytic Isoforms","volume":"281","author":"Mar\u00edn-Hern\u00e1ndez","year":"2014","journal-title":"FEBS J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic Reprogramming: The Emerging Concept and Associated Therapeutic Strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2020.12.009","article-title":"Glycolysis-Induced Drug Resistance in Tumors\u2014A Response to Danger Signals","volume":"23","author":"Marcucci","year":"2021","journal-title":"Neoplasia"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep44541","article-title":"Identification of the Metabolic Alterations Associated With the Multidrug Resistant Phenotype in Cancer and Their Intercellular Transfer Mediated by Extracellular Vesicles","volume":"7","author":"Lopes-Rodrigues","year":"2017","journal-title":"Nat Pub Group"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63104","article-title":"Intrinsic OXPHOS Limitations Underlie Cellular Bioenergetics in Leucemia","volume":"10","author":"Nelson","year":"2021","journal-title":"eLife."},{"key":"B47","doi-asserted-by":"publisher","first-page":"BSR20171383","DOI":"10.1042\/BSR20171383","article-title":"Overexpression of miR-202 Re-Sensitizes Imatinib Resistant Chronic Myeloid Leukemia Cells Through Targeting Hexokinase 2 (Hk2)","volume":"10","author":"Deng","year":"2018","journal-title":"Biosci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6189","article-title":"Glycometabolic Adaptation Mediates the Insensitivity of Drug-Resistant K562\/ADM Leukaemia Cells to Adriamycin via the AKT-mTOR\/C-Myc Signalling Pathway","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00104","article-title":"Classical NF-\u03bab Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2","volume":"8","author":"Londhe","year":"2018","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.2013.833607","article-title":"Targeting VDAC-Bound Hexokinase II: A Promising Approach for Concomitant Anti-Cancer Therapy","volume":"17","author":"Krasnov","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The Pentose Phosphate Pathway and Cancer Krushna","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4945","article-title":"Inhibition of Glucose-6-Phosphate Dehydrogenase Sensitizes Cisplatin-Resistant Cells to Death","volume":"6","author":"Catanzaro","year":"2015","journal-title":"Oncotarget"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4478-8","article-title":"Targeting P-Glycoprotein Expression and Cancer Cell Energy Metabolism: Combination of Metformin and 2-Deoxyglucose Reverses the Multidrug Resistance of K562\/Dox Cells to Doxorubicin","volume":"37","author":"Xue","year":"2016","journal-title":"Tum Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030462","article-title":"Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis","volume":"7","author":"Furtado","year":"2012","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0014-2999(02)02103-9","article-title":"Clotrimazole Decreases Glycolysis and the Viability of Lung Carcinoma and Colon Adenocarcinoma Cells","volume":"451","author":"Penso","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3922","article-title":"Evolutionary Consequences of Drug Resistance: Shared Principles Across Diverse Targets and Organisms","volume":"16","author":"Hughes","year":"2015","journal-title":"Nat Rev Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.leukres.2016.01.008","article-title":"Cell Differentiation and the Multiple Drug Resistance Phenotype in Human Erythroleukemic Cells","volume":"42","author":"Carrett-Dias","year":"2016","journal-title":"Leuk Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130555","article-title":"Nanomicellar Formulation of Clotrimazole Improves Its Antitumor Action Toward Human Breast Cancer Cells","volume":"10","author":"Marcondes","year":"2015","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20110571","article-title":"Hexokinase II Acts Through UCP3 to Suppress Mitochondrial Reactive Oxygen Species Production and Maintain Aerobic Respiration","volume":"437","author":"Mailloux","year":"2011","journal-title":"Biochem J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4304","article-title":"Dissociation of HKII in Retinal Epithelial Cells Induces Oxidative Stress Injury in the Retina","volume":"44","author":"Chu","year":"2019","journal-title":"Int J Mol Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.9.3735","article-title":"High Aerobic Glycolysis of Rat Hepatoma Cells in Culture: Role of Mitochondrial Hexokinase","volume":"74","author":"Bustamante","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2020.1867187","article-title":"Altered VDAC-HK Association and Apoptosis in Mouse Peripheral Blood Lymphocytes Exposed to Diabetic Condition: An In Vitro and In Vivo Study","author":"Sohlang","year":"2021","journal-title":"Arch Physiol Biochem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2019.129504","article-title":"Mitochondrial Glucose 6-Phosphate Dehydrogenase and 6-Phosphogluconate Dehydrogenase Abrogate P53 Induced Apoptosis in a Yeast Model: Possible Implications for Apoptosis Resistance in Cancer Cells","author":"Redhu","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.09","article-title":"Existing and Potential Therapeutic Uses for N-Acetylcysteine: The Need for Conversion to Intracellular Glutathione for Antioxidant Benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacol Ther"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32833e8022","article-title":"Clotrimazole Induces a Late G1 Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Radiation In Vitro","volume":"21","author":"Liu","year":"2010","journal-title":"Anti-Canc Drugs"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-534","article-title":"Clotrimazole Inhibits Cell Proliferation In Vitro and In Vivo","volume":"1","author":"Benzaquen","year":"1995","journal-title":"Nat Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2174\/0929867033457269","article-title":"Hexokinase II: The Integration of Energy Metabolism and Control of Apoptosis","volume":"10","author":"Pastorino","year":"2003","journal-title":"Curr Med Chem"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001852","article-title":"Hexokinase II Detachment From Mitochondria Triggers Apoptosis Through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels","volume":"3","author":"Chiara","year":"2008","journal-title":"PloS One"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2004.11.014","article-title":"Hexokinase-Mitochondria Interaction Mediated by Akt Is Required to Inhibit Apoptosis in the Presence or Absence of Bax and Bak","volume":"16","author":"Majewski","year":"2004","journal-title":"Mol Cell"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109950200","article-title":"Mitochondrial Binding of Hexokinase II Inhibits Bax-Induced Cytochrome C Release and Apoptosis","volume":"277","author":"Pastorino","year":"2002","journal-title":"J Biol Chem"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.07.003","article-title":"Is Resistance Useless? Multidrug Resistance and Collateral Sensitivity","volume":"30","author":"Hall","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.drup.2012.03.002","article-title":"Collateral Sensitivity as a Strategy Against Cancer Multidrug Resistance","volume":"15","author":"Pluchino","year":"2012","journal-title":"Drug Resist Update"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.07.020","article-title":"Induction of P-Glycoprotein Expression and Function in Human Intestinal Epithelial Cells (T84)","volume":"76","author":"Haslam","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1021\/bi701414f","article-title":"Complete Inhibition of the Pdr5p Multidrug Efflux Pump ATPase Activity by Its Transport Substrate Clotrimazole Suggests That GTP as Well as ATP May Be Used as an Energy Source","volume":"46","author":"Golin","year":"2007","journal-title":"Biochemistry"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-4439(97)00027-6","article-title":"Competitive, Non-Competitive and Cooperative Interactions Between Substrates of P-Glycoprotein as Measured by Its ATPase Activity","volume":"1361","author":"Litman","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1046\/j.0014-2956.2001.02611.x","article-title":"Effects of Clotrimazole on Transport Mediated by Multidrug Resistance Associated Protein 1 (MRP1) in Human Erythrocytes and Tumour Cells","volume":"268","author":"Klokouzas","year":"2001","journal-title":"Eur J Biochem FEBS"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2003.03753.x","article-title":"cGMP and Glutathione-Conjugate Transport in Human Erythrocytes","volume":"270","author":"Klokouzas","year":"2003","journal-title":"Eur J Biochem FEBS"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2006.06.008","article-title":"Transport of Glutathione and Glutathione Conjugates by MRP1","volume":"27","author":"Cole","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.05.017","article-title":"Collateral Sensitivity of Resistant MRP1-Overexpressing Cells to Flavonoids and Derivatives Through GSH Efflux","volume":"90","author":"Lorendeau","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.0c06662","article-title":"Theoretical Insights Into the Cotransport Mechanism of GSH With Anticancer Drugs by MRP1","volume":"124","author":"Zhao","year":"2020","journal-title":"J Phys Chem B"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.852985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T06:23:34Z","timestamp":1654237414000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.852985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":80,"alternative-id":["10.3389\/fonc.2022.852985"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.852985","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"article-number":"852985"}}